Scientific Publication References | Meso Scale Discovery

Results 1 - 50 of 61 for References

References	Journal	Year
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke Fiona Chapman, Sarah Jean Pour, Roman Wieczorek, Edgar Trelles Sticken, Jessica Budde, Karin Röwer, Sandra Otte, Elizabeth Mason, Lukasz Czekala, Thomas Nahde, Grant O’Connell, Liam Simms and Matthew Stevenson	Frontiers in Toxicology	2023	View
IL-6 as a Mediator of the Association Between Traditional Risk Factors and Future Myocardial Infarction: A Nested Case-Control Study Mulugeta M Zegeye, Jonas S O Andersson, Patrik Wennberg, Dirk Repsilber, Allan Sirsjö, Liza U Ljungberg	Arteriosclerosis, Thrombosis, and Vascular Biology	2021	View
Responsiveness to curcumin intervention is associated with reduced aortic stiffness in young, obese men with higher initial stiffness. MS Campbell, AJ Berrones, IM Krishnakumar, et al.	Journal of Functional Foods.	2017	View
Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. Bakhashab S, Ahmed FW, Schulten HJ, Bashir A, Karim S, Al-Malki AL, Gari MA, Abuzenadah AM, Chaudhary AG, Alqahtani MH, Lary S, Ahmed F, Weaver JU.	Cardiovasc Diabetol.	2016	View
Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion. Shmeleva EV, Boag SE, Murali S, Bennaceur K, Das R, Egred M, Purcell I, Edwards R, Todry S, Spyridopoulos I.	Immunity, Inflammation and Disease	2015	View
Splenic autonomic denervation increases inflammatory status but does not aggravate atherosclerotic lesion development. Kooijman S, Meurs I, van Beek L, Khedoe PP, Giezekamp A, Pike-Overzet K, Cailotto C, van der Vliet J, van Harmelen V, Boeckxstaens G, Berbée JF, Rensen PC.	Am J Physiol Heart Circ Physiol.	2015	View
A Common Polymorphism in Extracellular Superoxide Dismutase Affects Cardiopulmonary Disease Risk by Altering Protein Distribution. Hartney JM, Stidham T, Goldstrohm DA, Oberley-Deegan RE, Weaver MR, Valnickova-Hansen Z, Scavenius C, Benninger RK, Leahy KF, Johnson R, Gally F, Kosmider B, Zimmermann AK, Enghild JJ, Nozik-Grayck E, Bowler RP.	Circ Cardiovasc Genet.	2014	View
Mild oxidative damage in the diabetic rat heart is attenuated by glyoxalase-1 overexpression. Brouwers O, de Vos-Houben JMJ, Niessen PMG, Miyata T, van Nieuwenhoven F, Janssen BJA, Hageman G, Stehouwer CDA, Schalkwijk CG.	Int. J. Mol. Sci.	2013	View
A multiple ascending dose study of CSL112, an infused formulation of ApoA-I. Easton R, Gille A, D'Andrea D, Davis R,	J Clin Pharmacol.	2013	View
A sensitive and specific quantitation method for determination of serum cardiac Myosin binding protein-C by electrochemiluminescence immunoassay. Kuster DW, Barefield D, Govindan S, Sadayappan S.	J Vis Exp.	2013	View
Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity. Lamore SD, Kamendi HW, Scott CW, Dragan YP, Peters MF.	Toxicol Sci.	2013	View
Doxycycline reduces cardiac Matrix Metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass. Schulze CJ, Castro MM, Kandasamy AD, Cena J, Bryden C, Wang SH, Koshal A, Tsuyuki RT, Finegan BA, Schulz R.	Crit Care Med.	2013	View
Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery. Guan X, Mack DL, Moreno CM, Strande JL, Mathieu J, Shi Y, Markert CD, Wang Z, Liu G, Lawlor MW, Moorefield EC, Jones TN, Fugate JA, Furth ME, Murry CE, Ruohola H.	Stem Cell Research	2013	View
Susceptibility of adult and senescent Brown Norway rats to repeated ozone exposure: an assessment of behavior, serum biochemistry and cardiopulmonary function. Gordon CJ, Jarema KA, Lehmann JR, Ledbetter AD, Schladweiler MC, Schmid JE, Ward WO, Kodavanti UP, Nyska A, MacPhail RC.	Inhal Toxicol	2013	View
Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test Nolan N, Tee L, Vijayakumar S, Burazor I, Hytopoulos E, Biggs WH, Beggs M, French C, Harrington DS.	Expert Opin Med Diagn	2012	View
Arachidonate 15-Lipoxygenase Type B Knockdown Leads to Reduced Lipid Accumulation and Inflammation in Atherosclerosis. Magnusson, LU, Lundqvist A, Karlsson MN, Skalen K, Levin M, Wiklund O, Boren J, Hulten LM.	PLoS One	2012	View
Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats. Tonomura Y, Matsushima S, Kashiwagi E, Fujisawa K, Takagi S, Nishimura Y, Fukushima R, Torii M, Matsubara M.	Toxicology.	2012	View
Clinical and biomarker profile of trauma-induced secondary cardiac injury. De'Ath HD, Rourke C, Davenport R, Manson J, Renfrew I, Uppal R, Davies LC, Brohi K.	Br J Surg.	2012	View
Elevated remnant lipoproteins may increase subclinical CVD risk in pre-pubertal children with obesity: a case-control study. Wang Y, Pendlebury C, Dodd MM, Maximova K, Vine DF, Jetha MM, Ball GD, Proctor SD.	Pediatr Obes.	2012	View
Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Shami A, Gustafsson R, Kalamajski S, Krams R, Segers D, Rauch U, Roos G, Nilsson J, Oldberg A, Hultgårdh-Nilsson A.	Arterioscler Thromb Vasc Biol	2012	View
Genetic Variants in Platelet Factor 4 Modulate Inflammatory and Platelet Activation Biomarkers. Bhatnagar P, Lu X, Evans MK, Laveist TA, Zonderman AB, Carter DL, Arking DE, Fletcher CA.	Circ Cardiovasc Genet.	2012	View
In vitro and clinical studies examining the expression of osteopontin in cigarette smoke-exposed endothelial cells and cigarette smokers. Bishop E, Theophilus EH, Fearon IM.	BMC Cardiovascular Disorders	2012	View
Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr−/− mice compared to nondiabetic LDLr−/− mice Engelbertsen D, To F, Duner P, Kotova O, Soderberg I, Alm R, Gomez MF, Nilsson J, Bengtsson E.	Experimental Diabetes Research	2012	View
Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. Phelan D, Watson C, Martos R, Collier P, Patle A, Donnelly S, Ledwidge M, Baugh J, McDonald K.	PLoS One.	2012	View
Pharmacokinetics and biodistribution of a human monoclonal antibody to oxidized LDL in cynomolgus monkey using PET imaging. Kamath AV, Williams SP, Bullens S, Cowan KJ, Stenberg Y, Cherry SR, Rendig S, Kukis DL, Griesemer C, Damico-Beyer LA, Bunting S.	PLoS One	2012	View
Pharmacologically Dosed Oral Glutamine Reduces Myocardial Injury in Patients Undergoing Cardiac Surgery: A Randomized Pilot Feasibility Trial. Sufit A, Weitzel LB, Hamiel C, Queensland K, Dauber I, Rooyackers O, Wischmeyer PE.	J Parenter Enteral Nutr.	2012	View
Safety, tolerability, pharmacokinetics, and pharmacodynamics of Losmapimod following a single intravenous or oral dose in healthy volunteers. Barbour AM, Sarov-Blat L, Cai G, Fossler MJ, Sprecher DL, Graggaber J, McGeoch AT, Maison J, Cheriyan J.	Br J Clin Pharmacol.	2012	View
Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis. Sun L, Isaak CK, Zhou Y, Petkau JC, O K, Liu Y, Siow YL.	Life Sci.	2012	View
The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats. Hocher B, Sharkovska Y, Mark M, Klein T, Pfab T.	Int J Cardiol.	2012	View
Ways of coping and biomarkers of an increased atherothrombotic cardiovascular disease risk in elderly individuals. von Kanel R, Mausbach BT, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Ziegler MG, Roepke SK, Allison M, Grant I.	Cardiovascular Psychiatry and Neurology	2012	View
Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Cai, J., Hong, Y., Weng, C., Tan, C., Imperato-McGinley, J., Zhu, Y.S.	Am J Physiol Heart Circ Physiol.	2011	View
Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Collier, P., Watson, C.J., Voon, V., Phelan, D., Jan, A., Mak, G., Martos, R., Baugh, J.A., Ledwidge, M.T., McDonald, K.M.	Eur J Heart Fail.	2011	View
Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. van Bussel, B.C., Schouten, F., Henry, R.M., Schalkwijk, C.G., de Boer, M.R., Ferreira, I., Smulders, Y.M., Twisk, J.W., Stehouwer, C.D.	Hypertension.	2011	View
E-Selectin is Elevated in Cord Blood of South Asian Neonates Compared with Caucasian Neonates. Boon MR, Karamali NS, de Groot CJ, van Steijn L, Kanhai HH, van der Bent C, Berbée JF, Middelkoop B, Rensen PC, Tamsma JT.	J Pediatr.	2011	View
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Rayner, K.J., Esau, C.C., Hussain, F.N., McDaniel, A.L., Marshall, S.M., van Gils, J.M., Ray, T.D., Sheedy, F.J., Goedeke, L., Liu, X., Khatsenko, O.G., Kaimal, V., Lees, C.J., Fernandez-Hernando, C., Fisher, E.A., Temel, R.E., Moore, K.J.	Nature.	2011	View
Proteomic analysis of coronary sinus serum reveals leucine-rich a2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure Watson, C.J., Ledwidge, M.T., Phelan, D., Collier, P., Byrne, J.C., Dunn, M.J., McDonald, K.M., Baugh, J.A.	Circ Heart Fail.	2011	View
Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation. Levin, M.C., Jirholt, P., Wramstedt, A., Johansson, M.E., Lundberg, A.M., Gustafsson, T.M., Ståhlman, M., Fogelstrand, P., Brisslert, M., Fogelstrand, L., Yan, Z.Q., Hansson, G.K., Björkback, H., Olofsson, S.O., Borén, J.	Circ Res.	2011	View
Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study. Aronis, K.N., Vamvini, M.T., Chamberland, J.P., Sweeney, L.L., Brennan, A.M., Magkos, F., Mantzoros, C.S.	Metabolism.	2011	View
Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE(-/-) mice. Bernberg E, Ulleryd MA, Johansson ME, Bergström GM.	Atherosclerosis	2011	View
Androgen Receptor-Dependent and Independent Atheroprotection by Testosterone in Male Mice. Bourghardt, J., Wilhelmson, A.S., Alexanderson, C., De Gendt, K., Verhoeven, G., Krettek, A., Ohlsson, C., Tivesten, A.	Endocrinology	2010	View
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/- mice. Kolbus, D., Ramos, O.H., Berg, K.E., Persson, J., Wigren, M., Bjorkbacka, H., Fredrikson, G.N., Nilsson, J.	BMC Immunology.	2010	View
Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicity. French, K.J., Coatney, R.W., Renninger, J.P., Hu, C.X., Gales, T.L., Zhao, S., Storck, L.M., Davis, C.B., McSurdy-Freed, J., Chen, E., Frazier, K.S.	Toxicol Pathol.	2010	View
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Soon, E., Holmes, A.M., Treacy, C.M., Doughty, N.J., Southgate, L., Machado, R.D., Trembath, R.C., Jennings, S., Barker, L., Nicklin, P., Walker, C., Budd, D.C., Pepke-Zaba, J., Morrell, N.W.	Circulation.	2010	View
FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Zhao, M., Wigren, M., Dunér, P., Kolbus, D., Olofsson, K.E., Björkback, H., Nilsson, J., Fredrikson, G.N.	J Immunol Methods	2010	View
Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe-/- mice. Duner, P., To, F., Berg, K., Alm, R., Björkbacka, H., Engelbertsen, D., Fredrikson, G.N., Nilsson, J., Bengtsson, E.	Atherosclerosis.	2010	View
mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Song, X., Kusakari, Y., Xiao, C.Y., Kinsella, S.D., Rosenberg, M.A., Scherrer-Crosbie, M., Hara, K., Rosenzweig, A., Matsui, T.	Am J Physiol Cell Physiol.	2010	View
No increases in biomarkers of genetic damage or pathological changes in heart and brain tissues in male rats administered methylphenidate hydrochloride (Ritalin) for 28 days. Witt, K.L., Malarkey, D.E., Hobbs, C.A., Davis, J.P., Kissling, G.E., Caspary, W., Travlos, G., Recio, L.	Environ Mol Mutagen.	2010	View
Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the mayo clinic proteomic markers of arteriosclerosis study. Kim, C.X., Bailey, K.R., Klee, G.G., Ellington, A.A., Liu, G., Mosley, T.H. Jr, Rehman, H., Kullo, I.J.	Cancer Chemother Pharmacol.	2010	View
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. Ford, E.S., Greenwald, J.H., Richterman, A.G., Rupert, A., Dutcher, L., Badralmaa, Y., Natarajan, V., Rehm, C., Hadigan, C., Sereti, I.	AIDS	2010	View
Veterinary and toxicological applications for the detection of cardiac injury using cardiac troponin. Serra M, Papakonstantinou S, Adamcova M, O'Brien PJ.	Vet J. 2010 Jul;185(1):50-7.	2010	View

Results 1 - 50 of 61 for References

Please Sign In

User name

Password

References

Search References

Year

Species

Disease Focus

Products

Services

Orders & Support

Key Topics